• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

X连锁无丙种球蛋白血症患者Btk基因的基因组结构及外显子突变扫描

Genomic organization of the Btk gene and exon scanning for mutations in patients with X-linked agammaglobulinemia.

作者信息

Hagemann T L, Chen Y, Rosen F S, Kwan S P

机构信息

Department of Immunology, Rush Medical School, Chicago, IL 60612.

出版信息

Hum Mol Genet. 1994 Oct;3(10):1743-9. doi: 10.1093/hmg/3.10.1743.

DOI:10.1093/hmg/3.10.1743
PMID:7880320
Abstract

The defective gene responsible for the recessively inherited immunodeficiency X-linked agammaglobulinemia (XLA) has been shown to encode a cytoplasmic protein tyrosine kinase of the Src family designated Btk (Bruton's tyrosine kinase). To facilitate the search for germline mutations of the Btk gene, we have characterized its genomic structure. Eighteen introns were positioned within the approximately 37 kb gene. Each of the exon/intron boundaries were defined and sequenced, and all but two conform to consensus sequences. We have utilized the genomic organization of Btk and the intervening sequence data to design an assay for amplifying each of the 19 exons from XLA patient DNA for single strand conformation polymorphism (SSCP) analysis. By using this method we have identified mutations in 12 of 14 unrelated affected males: seven different base substitutions and two small deletions. Two of the mutations described in exon 15 of the kinase domain were found in more than one patient and may represent a mutation hot spot. Exon scanning has proven to be a valuable method for identifying the patient mutations in genomic DNA without the use of cDNA. The mutations are easily confirmed with direct sequencing of the amplified exons. This approach will greatly benefit XLA family studies involving carrier detection and prenatal diagnosis. In addition, the mutations identified may reveal residues involved in the specific protein interactions necessary in the B-cell developmental pathway, of which Btk is an integral component.

摘要

导致隐性遗传免疫缺陷——X连锁无丙种球蛋白血症(XLA)的缺陷基因已被证明编码一种Src家族的细胞质蛋白酪氨酸激酶,称为Btk(布鲁顿酪氨酸激酶)。为便于寻找Btk基因的种系突变,我们已对其基因组结构进行了表征。在大约37 kb的基因内定位了18个内含子。确定并测序了每个外显子/内含子边界,除两个外均符合共有序列。我们利用Btk的基因组组织和居间序列数据设计了一种检测方法,用于从XLA患者DNA中扩增19个外显子中的每一个,以进行单链构象多态性(SSCP)分析。通过使用这种方法,我们在14名无关的受影响男性中的12名中鉴定出了突变:7种不同的碱基替换和2种小缺失。激酶结构域第15外显子中描述的两种突变在不止一名患者中被发现,可能代表一个突变热点。外显子扫描已被证明是一种在不使用cDNA的情况下识别基因组DNA中患者突变的有价值方法。通过对扩增外显子的直接测序可以很容易地确认这些突变。这种方法将极大地有利于涉及携带者检测和产前诊断的XLA家系研究。此外,所鉴定的突变可能揭示B细胞发育途径中特定蛋白质相互作用所必需的残基,而Btk是该途径不可或缺的组成部分。

相似文献

1
Genomic organization of the Btk gene and exon scanning for mutations in patients with X-linked agammaglobulinemia.X连锁无丙种球蛋白血症患者Btk基因的基因组结构及外显子突变扫描
Hum Mol Genet. 1994 Oct;3(10):1743-9. doi: 10.1093/hmg/3.10.1743.
2
Screening of genomic DNA to identify mutations in the gene for Bruton's tyrosine kinase.筛选基因组DNA以鉴定布鲁顿酪氨酸激酶基因中的突变。
Hum Mol Genet. 1994 Oct;3(10):1751-6. doi: 10.1093/hmg/3.10.1751.
3
Detection of a novel mutation in the SRC homology domain 2 (SH2) of Bruton's tyrosine kinase and direct female carrier evaluation in a family with X-linked agammaglobulinemia.布鲁顿酪氨酸激酶SRC同源结构域2(SH2)中一种新突变的检测及对一个X连锁无丙种球蛋白血症家族女性携带者的直接评估。
Am J Med Genet. 1996 May 3;63(1):318-22. doi: 10.1002/(SICI)1096-8628(19960503)63:1<318::AID-AJMG53>3.0.CO;2-N.
4
An exon-skipping mutation in the btk gene of a patient with X-linked agammaglobulinemia and isolated growth hormone deficiency.一名患有X连锁无丙种球蛋白血症和孤立性生长激素缺乏症患者的btk基因外显子跳跃突变。
FEBS Lett. 1994 Jun 13;346(2-3):165-70. doi: 10.1016/0014-5793(94)00457-9.
5
DNA-based mutation analysis of Bruton's tyrosine kinase gene in patients with X-linked agammaglobulinaemia.X连锁无丙种球蛋白血症患者布鲁顿酪氨酸激酶基因的基于DNA的突变分析。
Hum Mol Genet. 1995 Jan;4(1):51-8. doi: 10.1093/hmg/4.1.51.
6
Deletion within the Src homology domain 3 of Bruton's tyrosine kinase resulting in X-linked agammaglobulinemia (XLA).布鲁顿酪氨酸激酶的Src同源结构域3内的缺失导致X连锁无丙种球蛋白血症(XLA)。
J Exp Med. 1994 Aug 1;180(2):461-70. doi: 10.1084/jem.180.2.461.
7
The genomic structure of human BTK, the defective gene in X-linked agammaglobulinemia.人类BTK的基因组结构,X连锁无丙种球蛋白血症中的缺陷基因。
Immunogenetics. 1994;40(5):319-24. doi: 10.1007/BF01246672.
8
Mutation analysis of the Bruton's tyrosine kinase gene in X-linked agammaglobulinemia: identification of a mutation which affects the same codon as is altered in immunodeficient xid mice.X连锁无丙种球蛋白血症中布鲁顿酪氨酸激酶基因的突变分析:鉴定出一个与免疫缺陷xid小鼠中发生改变的密码子相同的突变。
Hum Mol Genet. 1994 Jan;3(1):161-6. doi: 10.1093/hmg/3.1.161.
9
Genomic organization and structure of Bruton agammaglobulinemia tyrosine kinase: localization of mutations associated with varied clinical presentations and course in X chromosome-linked agammaglobulinemia.布鲁顿无丙种球蛋白血症酪氨酸激酶的基因组组织与结构:与X染色体连锁无丙种球蛋白血症不同临床表现及病程相关的突变定位
Proc Natl Acad Sci U S A. 1994 Sep 13;91(19):9062-6. doi: 10.1073/pnas.91.19.9062.
10
Molecular and structural characterization of five novel mutations in the Bruton's tyrosine kinase gene from patients with X-linked agammaglobulinemia.X连锁无丙种球蛋白血症患者布鲁顿酪氨酸激酶基因五个新突变的分子和结构特征
Mol Med. 1997 Jul;3(7):477-85.

引用本文的文献

1
Fatal X-linked agammaglobulinemia complicated by septic shock: a case report and comprehensive review of novel BTK mutations.致命性X连锁无丙种球蛋白血症合并感染性休克:一例报告及新型布鲁顿酪氨酸激酶(BTK)突变的综合综述
Front Immunol. 2025 Aug 15;16:1645337. doi: 10.3389/fimmu.2025.1645337. eCollection 2025.
2
EBV-Driven HLH and T Cell Lymphoma in a Child with X-Linked Agammaglobulinemia: A Genetically Confirmed Case Report and Literature Review.X连锁无丙种球蛋白血症患儿中的EBV驱动的噬血细胞性淋巴组织细胞增生症和T细胞淋巴瘤:一例基因确诊病例报告及文献复习
J Pers Med. 2025 Aug 9;15(8):365. doi: 10.3390/jpm15080365.
3
CaMKK2 as an emerging treatment target for bipolar disorder.
钙调蛋白激酶激酶 2 作为双相情感障碍的新兴治疗靶点。
Mol Psychiatry. 2023 Nov;28(11):4500-4511. doi: 10.1038/s41380-023-02260-3. Epub 2023 Sep 20.
4
Future Perspectives of Newborn Screening for Inborn Errors of Immunity.新生儿免疫缺陷病筛查的未来展望
Int J Neonatal Screen. 2021 Nov 2;7(4):74. doi: 10.3390/ijns7040074.
5
Clinical characteristics and genetic profiles of 174 patients with X-linked agammaglobulinemia: Report from Shanghai, China (2000-2015).174例X连锁无丙种球蛋白血症患者的临床特征与基因谱:来自中国上海的报告(2000 - 2015年)
Medicine (Baltimore). 2016 Aug;95(32):e4544. doi: 10.1097/MD.0000000000004544.
6
Splice-correction strategies for treatment of X-linked agammaglobulinemia.用于治疗X连锁无丙种球蛋白血症的剪接校正策略。
Curr Allergy Asthma Rep. 2015 Mar;15(3):510. doi: 10.1007/s11882-014-0510-0.
7
Ibrutinib and novel BTK inhibitors in clinical development.伊布替尼和处于临床开发阶段的新型 BTK 抑制剂。
J Hematol Oncol. 2013 Aug 19;6:59. doi: 10.1186/1756-8722-6-59.
8
Four novel and three recurrent mutations of the BTK gene and pathogenic effects of putative splice mutations.BTK基因的四个新突变和三个复发突变以及推定剪接突变的致病作用。
J Hum Genet. 2006;51(11):1006-1014. doi: 10.1007/s10038-006-0052-y. Epub 2006 Sep 2.
9
XLA patients with BTK splice-site mutations produce low levels of wild-type BTK transcripts.患有布鲁顿酪氨酸激酶(BTK)剪接位点突变的X连锁无丙种球蛋白血症(XLA)患者产生低水平的野生型BTK转录本。
J Clin Immunol. 2002 Sep;22(5):306-18. doi: 10.1023/a:1019982206951.
10
Stability and peptide binding specificity of Btk SH2 domain: molecular basis for X-linked agammaglobulinemia.布鲁顿酪氨酸激酶(Btk)SH2结构域的稳定性和肽结合特异性:X连锁无丙种球蛋白血症的分子基础
Protein Sci. 2000 Dec;9(12):2377-85. doi: 10.1110/ps.9.12.2377.